Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00246493 · ClinicalTrials.gov registry record
Vascular Aging: The Link That Bridges Age to Atherosclerosis (The VALIDATE Study)
A clinical trial, sponsored by National Institute on Aging (NIA).
- Terminated
- Registry status
- 495
- Enrollment target
NCT00246493 is a clinical trial that was terminated before completion, run by National Institute on Aging (NIA). The registered enrollment target is 495 participants.
The verdict
NCT00246493 was terminated before completion, sponsored by National Institute on Aging (NIA).
- TERMINATED
- Registry status
- 495 participants
- Enrollment target
Study Summary
The prevalence, incidence, and severity of atherosclerotic disease all markedly increase with age. Basic experimental and observational data demonstrate that aging magnifies the pathologic and clinical consequences of established risk factors and is the most potent individual risk factor for coronary atherosclerosis and for adverse outcomes following an ischemic event. These findings suggest that normal aging alters the vascular substrate so as to promote the development and progression of atherosclerosis. The age-associated changes in vascular structure and function include an increase in central vascular stiffness, intimal proliferation, and endothelial dysfunction. The major hypothesis is that the above alterations in vascular substrate (i.e. vascular age) are an important determinant of the age associated increased likelihood for the development and progression of coronary atherosclerotic disease. This program will non-invasively characterize vascular age and atherosclerotic burden in BLSA participants and individuals with successful aging, i.e. those with no or minimal evidence of coronary atherosclerotic disease, and those with premature, clinically evident coronary artery disease. It will repeat measures of vascular age and atherosclerotic burden three years after the first assessment. By examining the impact of vascular age on the initial extent and the progression of atherosclerotic burden over a two to three-year period, it will test the hypothesis that vascular age is an important determinant of the ageassociated increase in atherosclerotic disease....
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 495 participants |
| Start Date | 2004-06-22 |
| Est. Completion | 2017-11-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00246493
The ClinicalTrials.gov registry entry for NCT00246493 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 495 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute on Aging (NIA), which has 131 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00246493 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00246493 about?
NCT00246493 is a clinical study titled "Vascular Aging: The Link That Bridges Age to Atherosclerosis (The VALIDATE Study)". The prevalence, incidence, and severity of atherosclerotic disease all markedly increase with age. Basic experimental and observational data demonstrate that aging magnifies the pathologic and clinical consequences of established risk factors and is the most potent individual risk factor for coronar...
What is the current status of trial NCT00246493?
This trial is currently terminated. The enrollment target is 495 participants. The study started on 2004-06-22. Estimated completion is 2017-11-01.
Who is sponsoring clinical trial NCT00246493?
This trial is sponsored by National Institute on Aging (NIA), which has 131 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.